Robotic Rehabilitation for Stroke
(Aim2&3 Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that robot-assisted hand therapy can help improve movement and function in the arms and hands of stroke patients. It is often as effective, or even more effective, than traditional therapy, especially when used early in the rehabilitation process.
12345Research on robotic rehabilitation devices, like the RobHand exoskeleton, shows they are generally safe for humans, with no significant adverse events reported, such as skin lesions or fatigue. Safety assessments of rehabilitation robots focus on preventing excessive forces on the body, and current studies suggest these devices are safe when used correctly.
678910The IntelliArm treatment is unique because it uses a robotic device to assist with hand movements, allowing for more repetitions of specific tasks, which can lead to better motor and functional improvements in the upper limb compared to traditional therapies. This robot-assisted therapy can be personalized and used at home, making it a flexible option for stroke rehabilitation.
123411Eligibility Criteria
This trial is for individuals who had their first stroke 1-12 months ago, can sit for 3 hours, and have an arm and hand recovery stage rated between 2-4. It's not suitable for those with severe pain or contracture in the upper extremity, apraxia, low mental status scores, recent Botox in the arm, or involvement in other gait/limb studies.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo robot-aided rehabilitation with either the IntelliArm or hand robot, involving passive stretching or movement followed by active therapy
Follow-up
Participants are monitored for changes in motor function and other outcomes post-treatment